OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comprehensive Proteomics Analysis of Stressed Human Islets Identifies GDF15 as a Target for Type 1 Diabetes Intervention
Ernesto Nakayasu, Farooq Syed, Sarah A. Tersey, et al.
Cell Metabolism (2020) Vol. 31, Iss. 2, pp. 363-374.e6
Open Access | Times Cited: 93

Showing 1-25 of 93 citing articles:

Growth/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune Checkpoint
Jörg Wischhusen, Ignacio Melero, Wolf H. Fridman
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 363

GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease
Dongdong Wang, Emily A. Day, Logan K. Townsend, et al.
Nature Reviews Endocrinology (2021) Vol. 17, Iss. 10, pp. 592-607
Closed Access | Times Cited: 312

Tutorial: best practices and considerations for mass-spectrometry-based protein biomarker discovery and validation
Ernesto Nakayasu, Marina Gritsenko, Paul Piehowski, et al.
Nature Protocols (2021) Vol. 16, Iss. 8, pp. 3737-3760
Open Access | Times Cited: 181

Targeting SLC7A11 improves efferocytosis by dendritic cells and wound healing in diabetes
Sophia Maschalidi, Parul Mehrotra, Burcu Nur Keçeli, et al.
Nature (2022) Vol. 606, Iss. 7915, pp. 776-784
Closed Access | Times Cited: 170

GDF15: A Hormone Conveying Somatic Distress to the Brain
Sam Lockhart, Vladimı́r Saudek, Stephen O’Rahilly
Endocrine Reviews (2020) Vol. 41, Iss. 4
Open Access | Times Cited: 162

Single-cell multi-omics analysis of human pancreatic islets reveals novel cellular states in type 1 diabetes
Maria Fasolino, Gregory W. Schwartz, Abhijeet R. Patil, et al.
Nature Metabolism (2022) Vol. 4, Iss. 2, pp. 284-299
Open Access | Times Cited: 104

The pathogenic “symphony” in type 1 diabetes: A disorder of the immune system, β cells, and exocrine pancreas
Mark A. Atkinson, Raghavendra G. Mirmira
Cell Metabolism (2023) Vol. 35, Iss. 9, pp. 1500-1518
Open Access | Times Cited: 45

Growth differentiation factor 15 protects against the aging‐mediated systemic inflammatory response in humans and mice
Ji Sun Moon, Ludger J.E. Goeminne, Jung Tae Kim∥, et al.
Aging Cell (2020) Vol. 19, Iss. 8
Open Access | Times Cited: 102

Advanced nanomaterials as sample technique for bio-analysis
Nianrong Sun, Hailong Yu, Hao Wu, et al.
TrAC Trends in Analytical Chemistry (2021) Vol. 135, pp. 116168-116168
Closed Access | Times Cited: 81

GFRAL-expressing neurons suppress food intake via aversive pathways
Paul V. Sabatini, Henriette Frikke‐Schmidt, Joe Arthurs, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 8
Open Access | Times Cited: 62

Overview of growth differentiation factor 15 in metabolic syndrome
Mohamed Asrih, Shibo Wei, Thanh Thuy Nguyen, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 9, pp. 1157-1167
Open Access | Times Cited: 29

GDF15 Mediates the Effect of Skeletal Muscle Contraction on Glucose-Stimulated Insulin Secretion
Hui Zhang, Anny Mulya, Stephan Nieuwoudt, et al.
Diabetes (2023) Vol. 72, Iss. 8, pp. 1070-1082
Open Access | Times Cited: 26

Growth differentiation factor 15 (GDF-15) in endocrinology
Pedro Iglesias, Ramona A. Silvestre, Juan J. Díez
Endocrine (2023) Vol. 81, Iss. 3, pp. 419-431
Closed Access | Times Cited: 23

Plasma protein biomarkers predict the development of persistent autoantibodies and type 1 diabetes 6 months prior to the onset of autoimmunity
Ernesto Nakayasu, Lisa Bramer, Charles Ansong, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 7, pp. 101093-101093
Open Access | Times Cited: 22

Overview of growth differentiation factor 15 (GDF15) in metabolic diseases
Jian Li, Xiangjun Hu, Zichuan Xie, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116809-116809
Open Access | Times Cited: 13

Knocking on GDF15’s door for the treatment of type 2 diabetes mellitus
David Aguilar-Recarte, Emma Barroso, Xavier Palomer, et al.
Trends in Endocrinology and Metabolism (2022) Vol. 33, Iss. 11, pp. 741-754
Closed Access | Times Cited: 28

BET inhibitors synergize with sunitinib in melanoma through GDF15 suppression
Furong Zeng, Yayun Li, Yu Meng, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 2, pp. 364-376
Open Access | Times Cited: 17

Colchicine’s effects on metabolic and inflammatory molecules in adults with obesity and metabolic syndrome: results from a pilot randomized controlled trial
Andrew P. Demidowich, J Levine, Richard Apps, et al.
International Journal of Obesity (2020) Vol. 44, Iss. 8, pp. 1793-1799
Open Access | Times Cited: 46

Growth‐differentiation‐factor 15 levels in obese and healthy pregnancies: Relation to insulin resistance and insulin secretory function
Ulrika Andersson, Louise Joelsson, Pernilla Svedin, et al.
Clinical Endocrinology (2021) Vol. 95, Iss. 1, pp. 92-100
Open Access | Times Cited: 36

Camptothecin effectively treats obesity in mice through GDF15 induction
Jun Lu, Mengqing Zhu, Baocai Xie, et al.
PLoS Biology (2022) Vol. 20, Iss. 2, pp. e3001517-e3001517
Open Access | Times Cited: 26

An injectable ECM-like hydrogel with bioactive peptides and RepSox nanoparticles for myocardial infarction treatment
Zhicun Wang, Cheng Hu, Wen Zhang, et al.
Chemical Engineering Journal (2023) Vol. 474, pp. 145878-145878
Closed Access | Times Cited: 15

Total and H-specific GDF-15 levels increase in caloric deprivation independently of leptin in humans
Pavlina Chrysafi, Laura Valenzuela‐Vallejo, Konstantinos Stefanakis, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5

GDF-15 as a Weight Watcher for Diabetic and Non-Diabetic People Treated With Metformin
Jing Ouyang, Stéphane Isnard, John Lin, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 34

GDF-15, a future therapeutic target of glucolipid metabolic disorders and cardiovascular disease
Qing-Ao Xiao, Qian He, Jun Zeng, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 146, pp. 112582-112582
Open Access | Times Cited: 32

Page 1 - Next Page

Scroll to top